RESUMO
Modifications of DPP-4 inhibitor 5, that was discovered by structure based design, are described and structure-activity relationships discussed. With analogue 7k one of the most potent non-covalent inhibitors of DPP-4 reported to date (IC(50)=0.38nM) was discovered. X-ray structure of inhibitor 7k bound to DPP-4 revealed a hydrogen bonding interaction with Q553. First successful efforts in balancing overall properties, as demonstrated by improved metabolic stability, highlight the potential of this series.
Assuntos
Amidas/síntese química , Aminobutiratos/química , Inibidores da Dipeptidil Peptidase IV , Inibidores da Dipeptidil Peptidase IV/síntese química , Microssomos Hepáticos/efeitos dos fármacos , Sulfonamidas/síntese química , Amidas/farmacologia , Animais , Química Farmacêutica/métodos , Cristalografia por Raios X/métodos , Inibidores da Dipeptidil Peptidase IV/farmacologia , Desenho de Fármacos , Peptídeo 1 Semelhante ao Glucagon/antagonistas & inibidores , Ligação de Hidrogênio , Concentração Inibidora 50 , Microssomos Hepáticos/metabolismo , Ratos , Relação Estrutura-Atividade , Sulfonamidas/farmacologiaRESUMO
For a series of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV ADME properties were improved by the incorporation of amide replacements. These efforts led to a novel series of potent and selective inhibitors of DPP-4 that exhibit an attractive pharmacokinetic profile and show excellent efficacy in an animal model of diabetes.
Assuntos
Amidas/química , Aminobutiratos/química , Inibidores da Dipeptidil Peptidase IV , Relação Estrutura-Atividade , Amidas/antagonistas & inibidores , Células CACO-2 , Linhagem Celular Tumoral , Química Farmacêutica , Diabetes Mellitus Tipo 2/tratamento farmacológico , Inibidores da Dipeptidil Peptidase IV/uso terapêutico , Desenho de Fármacos , Humanos , Hipoglicemiantes/antagonistas & inibidores , Hipoglicemiantes/uso terapêutico , Inibidores de Proteases/farmacocinética , Inibidores de Proteases/farmacologia , Canais de Sódio/metabolismoRESUMO
A series of highly potent and selective inhibitors of DPP-4 was optimized for ADMET properties. The effort resulted in the discovery of inhibitor 1g, that exhibits excellent efficacy in an oral glucose tolerance test and an attractive pharmacokinetic profile.
Assuntos
Aminobutiratos/química , Inibidores da Dipeptidil Peptidase IV , Hidrocarbonetos Fluorados/química , Hipoglicemiantes/química , Inibidores de Proteases/química , Pirrolidinas/química , Administração Oral , Aminobutiratos/síntese química , Aminobutiratos/farmacocinética , Animais , Células CACO-2 , Linhagem Celular Tumoral , Dipeptidil Peptidase 4/metabolismo , Cães , Humanos , Hidrocarbonetos Fluorados/síntese química , Hidrocarbonetos Fluorados/farmacologia , Hipoglicemiantes/síntese química , Hipoglicemiantes/farmacocinética , Inibidores de Proteases/síntese química , Inibidores de Proteases/farmacocinética , Pirrolidinas/síntese química , Pirrolidinas/farmacologia , Ratos , Relação Estrutura-AtividadeRESUMO
The underlying frameworks of natural product classes with multiple biological activities can be regarded as biologically selected and prevalidated starting points in vast chemical structure space in the development of compound collections for chemical biology and medicinal chemistry research. For the synthesis of natural product-derived and -inspired compound collections, the development of enantioselective transformations in a format amenable to library synthesis, e.g., on the solid support, is a major and largely unexplored goal. We report on the enantioselective solid-phase synthesis of a natural product-inspired alpha,beta-unsaturated delta-lactone collection and its investigation in cell-based screens monitoring cell cycle progression and viral entry into cells. The screens identified modulators of both biological processes at a high hit rate. The screen for inhibition of viral entry opens up avenues of research for the identification of compounds with antiviral activity.
Assuntos
Produtos Biológicos/química , Ciclo Celular/efeitos dos fármacos , Lactonas/química , Lactonas/farmacologia , Internalização do Vírus/efeitos dos fármacos , Animais , Sítios de Ligação , Produtos Biológicos/metabolismo , Linhagem Celular , Cercopithecus , Técnicas de Química Combinatória , Desenho de Fármacos , Células HeLa , Humanos , Lactonas/síntese química , Lactonas/metabolismo , Conformação Molecular , Ligação Proteica , Estereoisomerismo , Vírus da Estomatite Vesicular IndianaRESUMO
The first total synthesis of aquatic peptide microcin SF608 is described. Coupling of L-Hpla with the dipeptide L-Phe-L-Choi followed by coupling with agmatine and a deprotection step gave microcin SF608. In addition, the levorotatory character of L-Hpla (5) was thoroughly established, and the conformational analysis of L-Choi containing peptides 1 and 8-10 was performed using NMR spectroscopy to examine the cis-trans isomer equilibrium of the L-Phe-L-Choi amide bond.